$SUND
Sundance Strategies, Inc. Stock $sund

$sund Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223022963 Filed on June 29, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$131.3K	$157.6K	$682.3K
YoY Change	-38.63%	25.08%	-1.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$44.00K	$157.6K	$682.3K
YoY Change	-38.03%	25.09%	-1.22%
Operating Profit	-$131.3K		-$682.3K
YoY Change	-38.63%		-1.22%
Interest Expense	$97.97K	-$62.09K	-$383.9K
YoY Change	32.15%	-66.02%	-20.92%
% of Operating Profit
Other Income/Expense, Net	-$206.9K		-$2.130M
YoY Change	136.07%		2.87%
Pretax Income	-$338.2K	-$1.588M	-$2.812M
YoY Change	12.13%	-27.13%	1.85%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$338.2K	-$1.588M	-$2.812M
YoY Change	12.13%	-27.13%	1.7%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01		-$0.07
Diluted Earnings Per Share	-$0.01	-$0.04	-$0.07
COMMON SHARES
Basic Shares Outstanding	41.41M shares	41.41M shares	41.41M shares
Diluted Shares Outstanding	41.41M shares		41.41M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.070K	$550.00	$550.00
YoY Change	-90.94%	-99.79%	-99.79%
Cash & Equivalents	$6.071K	$550.00	$550.00
Short-Term Investments
Other Short-Term Assets	$4.740K	$8.300K	$8.300K
YoY Change	1.5%	1.59%	1.59%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$10.81K	$8.850K	$8.850K
YoY Change	-84.91%	-96.8%	-96.79%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	-$1.00	$0.00	$0.00
YoY Change	-66.67%	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$10.81K	$8.850K	$8.850K
Total Long-Term Assets	-$1.00	$0.00	$0.00
Total Assets	$10.81K	$8.850K	$8.850K
YoY Change	-84.91%	-96.79%	-96.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$464.4K	$753.1K	$753.1K
YoY Change	-20.61%	29.62%	29.62%
Accrued Expenses	$229.6K	$574.6K	$574.6K
YoY Change	-39.87%	62.21%	62.21%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$300.0K	$300.0K
YoY Change	-100.0%	0.0%	0.0%
Long-Term Debt Due	$0.00	$876.0K	$876.0K
YoY Change	-100.0%	0.0%	0.0%
Total Short-Term Liabilities	$1.094M	$2.904M	$2.904M
YoY Change	-56.98%	15.63%	15.63%
LONG-TERM LIABILITIES
Long-Term Debt	$3.511M	$2.281M	$2.281M
YoY Change	65.18%	7.32%	7.32%
Other Long-Term Liabilities	$1.305M	$857.7K	$857.7K
YoY Change	78.38%	28.78%	28.78%
Total Long-Term Liabilities	$4.816M	$3.139M	$3.139M
YoY Change	68.56%	12.44%	12.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.094M	$2.904M	$2.904M
Total Long-Term Liabilities	$4.816M	$3.139M	$3.139M
Total Liabilities	$5.910M	$6.043M	$6.043M
YoY Change	9.45%	13.95%	13.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$35.40M	-$35.06M
YoY Change	8.75%	8.72%
Common Stock	$41.41K	$41.41K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.899M	-$6.034M	-$6.034M
YoY Change
Total Liabilities & Shareholders Equity	$10.81K	$8.850K	$8.850K
YoY Change	-84.91%	-96.8%	-96.79%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$338.2K	-$1.588M	-$2.812M
YoY Change	12.13%	-27.13%	1.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$106.4K	-$82.90K	-$459.7K
YoY Change	-47.04%	-55.29%	-43.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$112.0K	80.30K	192.3K
YoY Change		-79.93%	-81.86%
NET CHANGE
Cash From Operating Activities	-$106.4K	-82.90K	-459.7K
Cash From Investing Activities
Cash From Financing Activities	$112.0K	80.30K	192.3K
Net Change In Cash	$5.518K	-2.600K	-267.4K
YoY Change	-102.75%	-101.21%	-208.36%
FREE CASH FLOW
Cash From Operating Activities	-$106.4K	-$82.90K	-$459.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001171838
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q1	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-50547
CY2023	dei	Entity Registrant Name EntityRegistrantName	SUNDANCE STRATEGIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0515333
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4626 North 300 West
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite No. 365
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Provo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84604
CY2023	dei	City Area Code CityAreaCode	(801)
CY2023	dei	Local Phone Number LocalPhoneNumber	717-3935
CY2023	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2023	dei	Trading Symbol TradingSymbol	SUND
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41408441	shares
CY2022Q3	dei	Entity Public Float EntityPublicFloat	25630383	usd
CY2023	dei	Auditor Firm AuditorFirmId	3627
CY2023	dei	Auditor Name AuditorName	Sadler, Gibb & Associates, LLC
CY2023	dei	Auditor Location AuditorLocation	Draper, UT
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	553	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267966	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8295	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	8167	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8848	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	276133	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	753050	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	580972	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	574558	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	354205	usd
CY2023Q1	SUND	Stock Repurchase Payable Current StockRepurchasePayableCurrent	400000	usd
CY2022Q1	SUND	Stock Repurchase Payable Current StockRepurchasePayableCurrent	400000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2903608	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2511177	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	857685	usd
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	666015	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	2281463	usd
CY2022Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	2125808	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3139148	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2791823	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6042756	usd
CY2022Q1	us-gaap	Liabilities Liabilities	5303000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41408441	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41408441	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41408441	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41408441	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	41409	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	41409	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28986558	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	27181618	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35061875	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32249894	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5026867	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8848	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276133	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	682283	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	690709	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-682283	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-690709	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1745808	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1869971	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	285192	usd
CY2023	us-gaap	Interest Expense InterestExpense	329890	usd
CY2022	us-gaap	Interest Expense InterestExpense	287687	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	54000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	197761	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2129698	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2070227	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2811981	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2760936	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4149	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2765085	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41408441	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41218263	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-4716062	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	73920	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	500000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	40211	usd
CY2022	SUND	Warrants Issued In Connection To Extinguishment Of Debt WarrantsIssuedInConnectionToExtinguishmentOfDebt	1840149	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2765085	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5026867	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-5026867	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	126130	usd
CY2023	SUND	Warrants Issued In Connection To Extinguishment Of Debt WarrantsIssuedInConnectionToExtinguishmentOfDebt	1678810	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-6033908	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2811981	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2765085	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	73920	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	285192	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1745808	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1869971	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22487	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10389	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	128	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1226	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	172078	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27511	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	412023	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	309069	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-459713	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-813213	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	192300	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	260000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	300000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	57000	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	54000	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	197761	usd
CY2023	SUND	Additional Financing Alternatives AdditionalFinancingAlternatives	300000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	753050	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4149	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	500000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192300	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1060000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-267413	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	246787	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267966	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	21179	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	267966	usd
CY2023	SUND	Issued Warrants As Debt Issuance Costs IssuedWarrantsAsDebtIssuanceCosts	126130	usd
CY2022	SUND	Issued Warrants As Debt Issuance Costs IssuedWarrantsAsDebtIssuanceCosts	40211	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zKp7rTBMHqk6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zmkuyglbrmxa">Estimates</span>, </i>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9403644	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7250241	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	553	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	267966	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2021Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2023Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	310152	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	124225	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	124225	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	339749	shares
CY2022Q1	us-gaap	Share Price SharePrice	1.049
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0143	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.3178	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	40211	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10389	usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	29822	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	9403644	shares
CY2023Q1	SUND	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	9403644	shares
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8137574	usd
CY2023	SUND	Liquidity And Capital Requirements Disclosure Textblock LiquidityAndCapitalRequirementsDisclosureTextblock	<p id="xdx_809_ecustom--LiquidityAndCapitalRequirementsDisclosureTextblock_zWctVivwBo8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(9) <span id="xdx_829_zC2TC5IoO3T5">LIQUIDITY REQUIREMENTS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of March 31, 2023, the Company had $<span id="xdx_907_eus-gaap--Cash_iI_pp0p0_c20230331_zWFAFBynEae6">533</span> of cash assets, compared to $<span id="xdx_909_eus-gaap--Cash_iI_pp0p0_c20220331_zj4lRQAcGhv1">267,966</span> as of March 31, 2022. As of March 31, 2023, the Company had access to draw an additional $<span id="xdx_900_ecustom--AdditionalBorrowingCapacityFromRelatedPartyNotesPayable_iI_pp0p0_c20230331_zSirmcwyJsu3">4,411,892</span> on the notes payable, related party (see Note 8) and $<span id="xdx_905_ecustom--AdditionalBorrowingCapacityOnConvertibleDebenture_iI_pp0p0_c20230331_z8fwXKtkHTkd" title="Additional borrowing capacity from convertible debenture">3,000,000</span> on the Convertible Debenture Agreement (see Note 8). For the year ended March 31, 2023, the Company’s average monthly operating expenses were approximately $<span id="xdx_90A_eus-gaap--OperatingExpenses_pp0p0_c20220401__20230331_zWm46AEU34Ec" title="Operating Expenses">57,000</span>, which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and legal and accounting expenses. In addition to the monthly operating expenses, the Company continues to pursue other debt and equity financing opportunities, and as a result, financing expenses of $<span id="xdx_90E_eus-gaap--FinancingInterestExpense_pp0p0_c20220401__20230331_z1LSYHcHiD42">54,000</span> and $<span id="xdx_906_eus-gaap--FinancingInterestExpense_pp0p0_c20210401__20220331_z6oxiWiQqXd9">197,761</span> were incurred during the years ended March 31, 2023, and 2022, respectively. As management continues to explore additional financing alternatives, beginning April 1, 2023 the Company is expected to spend up to an additional $<span id="xdx_909_ecustom--AdditionalFinancingAlternatives_pp0p0_c20220401__20230331_zDmt2H1OvuL6">300,000</span> on these efforts. Outstanding Accounts Payable as of March 31, 2023 totaled $<span id="xdx_901_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pp0p0_c20230331_zEsP9LRh1Qk8">753,050</span>. Management has concluded that its existing capital resources and availability under its existing convertible debentures and debt agreements with related parties will be sufficient to fund its operating working capital requirements for the 12 months from the issuance of the financial statements. Related parties have given assurance that their continued support, by way of either extensions of due dates, or increases in lines-of-credit, can be relied on. As mentioned above, the Company also continues to evaluate other debt and equity financing opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Cash	533	usd
CY2022Q1	us-gaap	Cash Cash	267966	usd
CY2023Q1	SUND	Additional Borrowing Capacity From Related Party Notes Payable AdditionalBorrowingCapacityFromRelatedPartyNotesPayable	4411892	usd
CY2023Q1	SUND	Additional Borrowing Capacity On Convertible Debenture AdditionalBorrowingCapacityOnConvertibleDebenture	3000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-590516	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-579797	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-109962	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-103817	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	463012	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	468407	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	223229	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	215724	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	14237	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3632	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4149	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7387464	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7164235	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	479708	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	479708	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7867172	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7643943	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	29994131	usd
CY2023	SUND	Operating Loss Carryforwards Expiration Date Description OperatingLossCarryforwardsExpirationDateDescription	expire in 2023
CY2023	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	greater than 50 percent
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd

Files In Submission

Name	View Source	Status
0001493152-23-022963-index-headers.html	Edgar Link	pending
0001493152-23-022963-index.html	Edgar Link	pending
0001493152-23-022963.txt	Edgar Link	pending
0001493152-23-022963-xbrl.zip	Edgar Link	pending
ex10-40.htm	Edgar Link	pending
ex10-40_001.jpg	Edgar Link	pending
ex10-41.htm	Edgar Link	pending
ex10-41_001.jpg	Edgar Link	pending
ex10-42.htm	Edgar Link	pending
ex10-42_001.jpg	Edgar Link	pending
ex10-43.htm	Edgar Link	pending
ex10-43_001.jpg	Edgar Link	pending
ex10-44.htm	Edgar Link	pending
ex10-44_001.jpg	Edgar Link	pending
ex10-45.htm	Edgar Link	pending
ex10-45_001.jpg	Edgar Link	pending
ex10-46.htm	Edgar Link	pending
ex10-46_001.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sund-20230331.xsd	Edgar Link	pending
sund-20230331_cal.xml	Edgar Link	unprocessable
sund-20230331_def.xml	Edgar Link	unprocessable
sund-20230331_lab.xml	Edgar Link	unprocessable
sund-20230331_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SUND
Sundance Strategies, Inc. Stock $sund

2023 Q2 Form 10-K Financial Statement

#000149315223022963 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND Sundance Strategies, Inc. Stock $sund

2023 Q2 Form 10-K Financial Statement

#000149315223022963 Filed on June 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SUND
Sundance Strategies, Inc. Stock $sund